Blackbird Laboratories
Matt Tremblay, Ph.D., holds a Doctor of Philosophy in Chemistry from Columbia University. Currently, Matt serves as the Chief Executive Officer at Blackbird Laboratories and as the Board Chair at AIM-HI Accelerator Fund. In the past, Matt has held various leadership roles, including Chief Operating Officer at Scripps Research and California Institute for Biomedical Research, as well as a Research Investigator II at GNF. Matt's experience also includes being a Postdoctoral Fellow at The Scripps Research Institute and a Graduate Researcher at Columbia University. Currently, Matt is also a part of the Steering Board at Eshelman Institute for Innovation at UNC Eshelman School of Pharmacy.
Blackbird Laboratories
Blackbird Labs' mission is to help universities and investigators commercialize their academic research to build innovative companies, bring world-changing technologies to life, and create a thriving entrepreneurial ecosystem in Baltimore.